Sustained virologic response to standard interferon or pegylated interferon and ribavirin in patients with hepatitis C virus genotype 5: systematic review and meta-analysis of ten studies and 423 patients

被引：0
作者：
Pardha Devaki
David Jencks
Brittany E. Yee
Mindie H. Nguyen
机构：
[1] Cleveland Clinic,Digestive Disease Institute
[2] Veterans’ Administration Health Care System,Department of Medicine
[3] University of California,School of Medicine
[4] Stanford University Medical Center,Division of Gastroenterology and Hepatology
来源：
Hepatology International | 2015年 / 9卷
关键词：
Hepatitis C; Genotype 5; Sustained virologic response; Peginterferon and ribavirin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：431 / 437
页数：6
相关论文
共 50 条
  • [21] Lower Incidence of Hepatocellular Carcinoma and Cirrhosis in Hepatitis C Patients with Sustained Virological Response by Pegylated Interferon and Ribavirin
    Chansoo Moon
    Kyu Sik Jung
    Do Young Kim
    Oidov Baatarkhuu
    Jun Yong Park
    Beom Kyung Kim
    Seung Up Kim
    Sang Hoon Ahn
    Kwang-Hyub Han
    Digestive Diseases and Sciences, 2015, 60 : 573 - 581
  • [22] Meta-analysis: amantadine may lower the efficacy of pegylated interferon plus ribavirin in treatment-naive hepatitis C genotype 1 patients
    Chen, Jian
    Shi, Jian
    Xie, Wei-Fen
    Zeng, Xin
    Lin, Yong
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 (10) : E748 - E752
  • [23] Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: A meta-analysis
    Camma, Calogero
    Cabibbo, Giuseppe
    Bronte, Fabrizio
    Enea, Marco
    Licata, Anna
    Attanasio, Massimo
    Andriulli, Angelo
    Craxi, Antonio
    JOURNAL OF HEPATOLOGY, 2009, 51 (04) : 675 - 681
  • [24] Risk factors for hepatocellular carcinoma in Hepatitis C patients with sustained virologic response to interferon therapy
    Iwasaki, Y
    Takaguchi, K
    Ikeda, H
    Makino, Y
    Araki, Y
    Ando, M
    Kobashi, H
    Kobatake, T
    Tanaka, R
    Tomita, M
    Senoh, T
    Kawaguchi, M
    Shimoe, T
    Manabe, K
    Kita, K
    Shimamura, J
    Sakaguchi, K
    Shiratori, Y
    LIVER INTERNATIONAL, 2004, 24 (06) : 603 - 610
  • [25] Sustained virological response to pegylated interferon plus ribavirin leads to normalization of liver stiffness in hepatitis C virus-infected patients
    Macias, Juan
    Rivero, Antonio
    Cifuentes, Celia
    Camacho, Angela
    Neukam, Karin
    Rivero-Juarez, Antonio
    Mira, Jose A.
    Torre-Cisneros, Julian
    Gomez-Mateos, Jesus
    Pineda, Juan A.
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2013, 31 (07): : 424 - 429
  • [26] Vitamin D level and sustained virologic response to interferon-based antiviral therapy in chronic hepatitis C: A systematic review and meta-analysis
    Kitson, Matthew T.
    Sarrazin, Christoph
    Toniutto, Pierluigi
    Eslick, Guy D.
    Roberts, Stuart K.
    JOURNAL OF HEPATOLOGY, 2014, 61 (06) : 1247 - 1252
  • [27] Response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C due to genotype 4
    Martin-Carbonero, L.
    Puoti, M.
    Garcia-Samaniego, J.
    De Luca, A.
    Losada, E.
    Quinzan, G.
    Bruno, R.
    Marino, A.
    Gonzalez, M.
    Nunez, M.
    Soriano, V.
    JOURNAL OF VIRAL HEPATITIS, 2008, 15 (10) : 710 - 715
  • [28] Sustained virologic response and IL28B single-nucleotide polymorphisms in patients with chronic hepatitis C treated with pegylated interferon alfa and ribavirin
    Jablonowska, Elzieta
    Piekarska, Anna
    Koslinska-Berkan, Ewa
    Omulecka, Aleksandra
    Szymanska, Bozena
    Wojcik, Kamila
    ACTA BIOCHIMICA POLONICA, 2012, 59 (03) : 333 - 337
  • [29] Pulmonary complications associated with pegylated interferon and ribavirin in HIV/hepatitis C virus coinfected patients
    Benatti, Simone Vasilij
    Quinzan, Giampaolo
    Bigoni, Sara
    Rizzi, Marco
    Ripamonti, Diego
    AIDS, 2014, 28 (17) : 2633 - 2635
  • [30] A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C
    You, Byung Chul
    Kim, Young Seok
    Kim, Hun il
    Kim, Se Hun
    Park, Seung Sik
    Seo, Yu Ri
    Kim, Sang Gyune
    Lee, Se Whan
    Kim, Hong Soo
    Jeong, Soung Won
    Jang, Jae Young
    Kim, Boo Sung
    CLINICAL AND MOLECULAR HEPATOLOGY, 2012, 18 (03) : 272 - 278
12345